Acinetobacter infection – an emerging threat to human health

The genus Acinetobacter comprises a complex and heterogeneous group of bacteria, many of which are capable of causing a range of opportunistic, often catheter‐related, infections in humans. However, Acinetobacter baumannii, as well as its close relatives belonging to genomic species 3 (“Acinetobacter pittii”) and 13TU (“Acinetobacter nosocomialis”), are important nosocomial pathogens, often associated with epidemic outbreaks of infection, that are only rarely found outside of a clinical setting. These organisms are frequently pandrug‐resistant and are capable of causing substantial morbidity and mortality in patients with severe underlying disease, both in the hospital and in the community. Several epidemic clonal lineages of A. baumannii have disseminated worldwide and seem to have a selective advantage over non‐epidemic strains. The reasons for the success of these epidemic lineages remain to be elucidated, but could be related to the potential of these organisms to achieve very dynamic reorganization and rapid evolution of their genome, including the acquisition and expression of additional antibiotic resistance determinants, under fluctuating environmental and selective conditions. © 2011 IUBMB IUBMB Life, 63(12): 1048–1054, 2011

[1]  J. Heritage,et al.  Description of Leeds Acinetobacter Medium, a new selective and differential medium for isolation of clinically important Acinetobacter spp., and comparison with Herellea agar and Holton's agar , 1994, Journal of clinical microbiology.

[2]  P. Higgins,et al.  Global spread of carbapenem-resistant Acinetobacter baumannii. , 2010, The Journal of antimicrobial chemotherapy.

[3]  P. Janssen,et al.  Discrimination of Acinetobacter genomic species by AFLP fingerprinting. , 1997, International journal of systematic bacteriology.

[4]  K. Petersen,et al.  Acinetobacter baumannii skin and soft-tissue infection associated with war trauma. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  S. D. Henriksen Moraxella, Acinetobacter, and the Mimeae. , 1973, Bacteriological reviews.

[6]  S. Brisse,et al.  Molecular Epidemiology of Multidrug-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Naples, Italy, Shows the Emergence of a Novel Epidemic Clone , 2010, Journal of Clinical Microbiology.

[7]  H. Seifert,et al.  Nosocomial Bacteremia due to Acinetobacter baumannii: Clinical Features, Epidemiology, and Predictors of Mortality , 1995, Medicine.

[8]  M. Luczak,et al.  Biofilm production by clinical strains of Acinetobacter baumannii isolated from patients hospitalized in two tertiary care hospitals. , 2008, FEMS immunology and medical microbiology.

[9]  J. Garnacho-Montero,et al.  Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Erko Stackebrandt,et al.  Taxonomic Note: A Place for DNA-DNA Reassociation and 16S rRNA Sequence Analysis in the Present Species Definition in Bacteriology , 1994 .

[11]  K. Davis,et al.  Multidrug-Resistant Acinetobacter Extremity Infections in Soldiers , 2005, Emerging infectious diseases.

[12]  M. Vaneechoutte,et al.  Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species. , 1998, Systematic and applied microbiology.

[13]  I. Goic-Barisic,et al.  Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase. , 2011, The Journal of hospital infection.

[14]  M. Adams,et al.  Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. , 2010, The Journal of antimicrobial chemotherapy.

[15]  P. Visca,et al.  Genome-assisted identification of putative iron-utilization genes in Acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates. , 2011, Research in microbiology.

[16]  P. Higgins,et al.  gyrB Multiplex PCR To Differentiate between Acinetobacter calcoaceticus and Acinetobacter Genomic Species 3 , 2010, Journal of Clinical Microbiology.

[17]  Jonathan R Edwards,et al.  Overview of nosocomial infections caused by gram-negative bacilli. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  R. Wenzel,et al.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  M. Gillis,et al.  Taxonomy of Moraxellaceae fam. nov., a New Bacterial Family To Accommodate the Genera Moraxella, Acinetobacter, and Psychrobacter and Related Organisms , 1991 .

[20]  L. Dijkshoorn,et al.  Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. , 2006, Research in microbiology.

[21]  L. Dijkshoorn,et al.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii , 2007, Nature Reviews Microbiology.

[22]  Harald Seifert,et al.  Acinetobacter baumannii: Emergence of a Successful Pathogen , 2008, Clinical Microbiology Reviews.

[23]  R. Hall,et al.  Evolution of AbaR-type genomic resistance islands in multiply antibiotic-resistant Acinetobacter baumannii. , 2010, The Journal of antimicrobial chemotherapy.

[24]  L. Peixe,et al.  Understanding the dynamics of imipenem-resistant Acinetobacter baumannii lineages within Portugal. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[25]  A. Carattoli,et al.  Distribution of Intrinsic Plasmid Replicase Genes and Their Association with Carbapenem-Hydrolyzing Class D β-Lactamase Genes in European Clinical Isolates of Acinetobacter baumannii , 2011, Antimicrobial Agents and Chemotherapy.

[26]  P. Visca,et al.  Identification of Variable-Number Tandem-Repeat (VNTR) Sequences in Acinetobacter baumannii and Interlaboratory Validation of an Optimized Multiple-Locus VNTR Analysis Typing Scheme , 2010, Journal of Clinical Microbiology.

[27]  D. Paterson,et al.  Management of meningitis due to antibiotic-resistant Acinetobacter species. , 2009, The Lancet. Infectious diseases.

[28]  Chong-Jen Yu,et al.  Severe community-acquired pneumonia due to Acinetobacter baumannii. , 2001, Chest.

[29]  J. Heritage,et al.  Survival of Acinetobacter baumannii on Dry Surfaces: Comparison of Outbreak and Sporadic Isolates , 1998, Journal of Clinical Microbiology.

[30]  R. Gaynes,et al.  NATIONAL NOSOCOMIAL INFECTIONS SURVEILLANCE S. OVERVIEW OF NOSOCOMIAL INFECTIONS CAUSED BY GRAM-NEGATIVE BACILLI , 2005 .

[31]  R. Schmitt,et al.  Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii. , 2007, The Journal of hospital infection.

[32]  S. Valdezate,et al.  Clonal Diversity of Nosocomial Epidemic Acinetobacter baumannii Strains Isolated in Spain , 2010, Journal of Clinical Microbiology.

[33]  H. Seifert,et al.  Molecular Epidemiology of Acinetobacter Species , 2008 .

[34]  Qing Yang,et al.  Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China. , 2010, The Journal of antimicrobial chemotherapy.

[35]  P. Nordmann,et al.  Worldwide Dissemination of the blaOXA-23 Carbapenemase Gene of Acinetobacter baumannii1 , 2010, Emerging infectious diseases.

[36]  L. Dijkshoorn,et al.  The Population Structure of Acinetobacter baumannii: Expanding Multiresistant Clones from an Ancestral Susceptible Genetic Pool , 2010, PloS one.

[37]  J. Patel,et al.  An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  M. Kaufmann,et al.  Identification of Acinetobacter baumannii by Detection of the blaOXA-51-like Carbapenemase Gene Intrinsic to This Species , 2006, Journal of Clinical Microbiology.

[39]  M. Falagas,et al.  Attributable mortality of Acinetobacter baumannii: no longer a controversial issue , 2007, Critical care.

[40]  P. Higgins,et al.  A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[41]  Yee-Chun Chen,et al.  Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  P. Higgins,et al.  Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.